http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103239421-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b26e17432236aa949f62b08733832285 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
filingDate | 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_675f1515d719d2e941f05c3571c794ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42b1fbc7d417bd11b23a5bfa8fdf3992 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_804f0153f4eccf1c8ac167b4a5200dfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beb18a6ab82a22b53f04517a9e36955d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9847ca5a0c4e3f547689584db2e63600 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bbec5ee45705554eec75a61dfadc294 |
publicationDate | 2015-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103239421-B |
titleOfInvention | Fluvastatin sodium composition capsule and preparation method thereof |
abstract | The invention relates to the field of medicaments, and discloses a fluvastatin sodium composition capsule; the medicament effective components prepared into one thousand capsules include 15 to 40grams of fluvastatin sodium, 20 to 50grams of microcrystalline cellulose, 120-250grams of lactose, 4 to 10grams of hydroxypropylcellulose, 50 to 100grams of 3% starch slurry and 0.5 to 2.5grams of magnesium stearate. The invention also discloses a preparation method of the fluvastatin sodium composition capsule. The fluvastatin sodium composition capsule provided by the invention has the characteristics of low cost, high absorption rate after being taken, excellent therapeutic dose tolerance of patients, light adverse reaction and the like, and is a safe and effective lipid lowering medicament; in the preparation method, the whole process is simple and the process control parameter is easy to control, and therefore the preparation method is suitable for large-scale industrialized popularization. |
priorityDate | 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 409.